- Yang, Huilin;
- Ulge, Umut;
- Quijano-Rubio, Alfredo;
- Bernstein, Zachary;
- Maestas, David;
- Chun, Jung-Ho;
- Wang, Wentao;
- Lin, Jian-Xin;
- Jude, Kevin;
- Singh, Srujan;
- Orcutt-Jahns, Brian;
- Li, Peng;
- Mou, Jody;
- Chung, Liam;
- Kuo, Yun-Huai;
- Ali, Yasmin;
- Meyer, Aaron;
- Grayson, Warren;
- Heller, Nicola;
- Garcia, K;
- Leonard, Warren;
- Silva, Daniel-Adriano;
- Elisseeff, Jennifer;
- Baker, David;
- Spangler, Jamie
The interleukin-4 (IL-4) cytokine plays a critical role in modulating immune homeostasis. Although there is great interest in harnessing this cytokine as a therapeutic in natural or engineered formats, the clinical potential of native IL-4 is limited by its instability and pleiotropic actions. Here, we design IL-4 cytokine mimetics (denoted Neo-4) based on a de novo engineered IL-2 mimetic scaffold and demonstrate that these cytokines can recapitulate physiological functions of IL-4 in cellular and animal models. In contrast with natural IL-4, Neo-4 is hyperstable and signals exclusively through the type I IL-4 receptor complex, providing previously inaccessible insights into differential IL-4 signaling through type I versus type II receptors. Because of their hyperstability, our computationally designed mimetics can directly incorporate into sophisticated biomaterials that require heat processing, such as three-dimensional-printed scaffolds. Neo-4 should be broadly useful for interrogating IL-4 biology, and the design workflow will inform targeted cytokine therapeutic development.